Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00992433
What this trial is testing

H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 192
Not applicableStudy completedNCT00027352
What this trial is testing

A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6,000
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Early research (Phase 1)Study completedNCT04857892
What this trial is testing

A Relative Bioavailability and Food-Effect Study of the Fixed Dose Combination of GSK3640254 and Dolutegravir (DTG) in Healthy Participants

Who this might be right for
HIV Infections
ViiV Healthcare 41
Not applicableStudy completedNCT00002216
What this trial is testing

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Who this might be right for
HIV Infections
Glaxo Wellcome
Large-scale testing (Phase 3)Study completedNCT02282293
What this trial is testing

Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)

Who this might be right for
MalariaHuman Immunodeficiency Virus
University of California, San Francisco 200
Early research (Phase 1)UnknownNCT01259219
What this trial is testing

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Who this might be right for
Children With Confirmed HIV InfectionReceiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard DoseSuccessfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment
Harriet Shezi Children's Clinic 40
Not applicableStudy completedNCT00502944
What this trial is testing

Two Approaches to Routine HIV Testing in a Hospital Emergency Department

Who this might be right for
HIV Infections
Massachusetts General Hospital 4,855
Early research (Phase 1)Study completedNCT02799264
What this trial is testing

Evaluate the Effect of High Fat Meal on Cabotegravir

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 24
Large-scale testing (Phase 3)Study completedNCT00425984
What this trial is testing

Male Circumcision for HIV Prevention in Rakai, Uganda

Who this might be right for
HIV InfectionsHerpesvirus 2, HumanSyphilis+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Not applicableWithdrawnNCT00001070
What this trial is testing

The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)UnknownNCT04560569
What this trial is testing

Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection

Who this might be right for
HIV/AIDS
Frontier Biotechnologies Inc. 20
Large-scale testing (Phase 3)Study completedNCT01440569
What this trial is testing

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 314
Large-scale testing (Phase 3)Study completedNCT00639938
What this trial is testing

Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 722
Testing effectiveness (Phase 2)Study completedNCT00002423
What this trial is testing

Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

Who this might be right for
HIV Infections
Glaxo Wellcome 100
Large-scale testing (Phase 3)Study completedNCT04399551
What this trial is testing

A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries

Who this might be right for
HIV Infections
ViiV Healthcare 437
Post-approval studies (Phase 4)Study completedNCT04952766
What this trial is testing

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Who this might be right for
Kidney TransplantMyelomaCancer+6 more
Centre Hospitalier Régional d'Orléans 196
Testing effectiveness (Phase 2)Study completedNCT00476853
What this trial is testing

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 42
Not applicableStudy completedNCT05619497
What this trial is testing

The OPENS Trial: Offering Women PrEP (Aim 2)

Who this might be right for
Human Immunodeficiency VirusHuman Immunodeficiency Virus TransmissionSexually Transmitted Diseases
University of California, San Francisco 141
Testing effectiveness (Phase 2)Study completedNCT02405013
What this trial is testing

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa

Who this might be right for
Hepatitis CHIV Infection
ANRS, Emerging Infectious Diseases 120
Next Page